Recalls & Warnings July 04, 2017 FDA Warns Against Company's Unsafe Teething Tablets On June 20, 2017, the FDA issued a warning letter to Raritan Pharmaceuticals, Inc
Discussing your complete treatment approach with healthcare providers familiar with peptide therapy helps avoid counterproductive combinations
Nature 2018;562, 578-582, doi:10.1038/s41586-018-0543-y
Our Lipo B12 injections offer a convenient and effective way to replenish your B12 levels
BPC-157 carries a 2023 FDA Category 2 designation, and both are on the World Anti-Doping Agency prohibited list
However, some peptides are on the WADA list, meaning they are prohibited for use by professional athletes